Abby Luxon, Anxhela Syziu, William D Harrison, Amirul Islam, Lyndon Mason
{"title":"胫骨皮质横向转运治疗下肢缺血性溃疡的系统综述。","authors":"Abby Luxon, Anxhela Syziu, William D Harrison, Amirul Islam, Lyndon Mason","doi":"10.1177/10711007251341312","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Ischemic foot ulcers are a debilitating but common finding from many different conditions and can result in severe and life-threatening complications such as amputation and death. In recent years, tibial cortex transverse transport (TTT) has been used to treat ischemic ulcers with the aim to improve revascularization and wound healing. Our aim with this systematic review is to analyze the current literature to study the effects this surgery has on the treatment of ischemic ulcers of the lower limb.</p><p><strong>Methods: </strong>A search was conducted using the 3 databases Web of Science, PubMed, and Scopus to collate all articles associated with the use of TTT in the treatment of lower limb ischemic ulcers. Duplicate articles were removed, and the remaining articles were filtered and screened using set inclusion criteria such as patients with a diagnosed foot ulcer of ischemic origin, patients treated with TTT alone or combined with other techniques on the affected leg, unilateral or bilateral ischemic ulcers, studies that had evidence of treatment outcomes related to ulcer such as visual analog scale (VAS), ankle-brachial index (ABI) measurements, ulcer healing rate and time, recurrence rate, and complications. The exclusion criteria consisted of duplicated studies, overlapping data in studies, TTT used to treat nonulcerous conditions, other systematic reviews, articles with publication language other than English, no access to full text of article, and case reports.</p><p><strong>Results: </strong>A total of 13 articles were included in the final selection, involving 924 patients, with 724 treated with TTT, in which 701 were diabetic patients. The results extracted demonstrated improvements in healing rates and times, vascular endothelial growth factor, ABI scores, VAS scores, and limb salvage. With regard to the complications and risks, pin-site infections and tibial fractures were infrequent and treated quickly.</p><p><strong>Conclusion: </strong>Overall, the use of TTT has been associated with unusual success in improving revascularization and healing times in treating ischemic ulcers of the lower limb resulting in better outcomes for the patient and may provide a potential alternative treatment to the more conventional, widespread treatments currently used in clinical practice. Tibial fractures and pin-site infections are relatively rare complications that have been reported with use of this treatment.</p>","PeriodicalId":94011,"journal":{"name":"Foot & ankle international","volume":" ","pages":"914-924"},"PeriodicalIF":2.2000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12329156/pdf/","citationCount":"0","resultStr":"{\"title\":\"A Systematic Review on Tibial Cortex Transverse Transport in the Treatment of Ischemic Ulcers of the Lower Limb.\",\"authors\":\"Abby Luxon, Anxhela Syziu, William D Harrison, Amirul Islam, Lyndon Mason\",\"doi\":\"10.1177/10711007251341312\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Ischemic foot ulcers are a debilitating but common finding from many different conditions and can result in severe and life-threatening complications such as amputation and death. In recent years, tibial cortex transverse transport (TTT) has been used to treat ischemic ulcers with the aim to improve revascularization and wound healing. Our aim with this systematic review is to analyze the current literature to study the effects this surgery has on the treatment of ischemic ulcers of the lower limb.</p><p><strong>Methods: </strong>A search was conducted using the 3 databases Web of Science, PubMed, and Scopus to collate all articles associated with the use of TTT in the treatment of lower limb ischemic ulcers. Duplicate articles were removed, and the remaining articles were filtered and screened using set inclusion criteria such as patients with a diagnosed foot ulcer of ischemic origin, patients treated with TTT alone or combined with other techniques on the affected leg, unilateral or bilateral ischemic ulcers, studies that had evidence of treatment outcomes related to ulcer such as visual analog scale (VAS), ankle-brachial index (ABI) measurements, ulcer healing rate and time, recurrence rate, and complications. The exclusion criteria consisted of duplicated studies, overlapping data in studies, TTT used to treat nonulcerous conditions, other systematic reviews, articles with publication language other than English, no access to full text of article, and case reports.</p><p><strong>Results: </strong>A total of 13 articles were included in the final selection, involving 924 patients, with 724 treated with TTT, in which 701 were diabetic patients. The results extracted demonstrated improvements in healing rates and times, vascular endothelial growth factor, ABI scores, VAS scores, and limb salvage. With regard to the complications and risks, pin-site infections and tibial fractures were infrequent and treated quickly.</p><p><strong>Conclusion: </strong>Overall, the use of TTT has been associated with unusual success in improving revascularization and healing times in treating ischemic ulcers of the lower limb resulting in better outcomes for the patient and may provide a potential alternative treatment to the more conventional, widespread treatments currently used in clinical practice. Tibial fractures and pin-site infections are relatively rare complications that have been reported with use of this treatment.</p>\",\"PeriodicalId\":94011,\"journal\":{\"name\":\"Foot & ankle international\",\"volume\":\" \",\"pages\":\"914-924\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2025-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12329156/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Foot & ankle international\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/10711007251341312\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/6/26 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Foot & ankle international","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/10711007251341312","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/26 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景:缺血性足溃疡是一种使人虚弱但常见的疾病,可导致严重和危及生命的并发症,如截肢和死亡。近年来,胫骨皮质横向转运(TTT)已被用于治疗缺血性溃疡,目的是改善血运重建和伤口愈合。我们系统回顾的目的是分析目前的文献,研究这种手术对下肢缺血性溃疡治疗的影响。方法:使用Web of Science、PubMed和Scopus 3个数据库进行检索,整理所有与使用TTT治疗下肢缺血性溃疡相关的文章。重复的文章被删除,剩余的文章被过滤和筛选,使用设定的纳入标准,如诊断为缺血性足溃疡的患者,在受影响的腿上单独或联合使用TTT治疗的患者,单侧或双侧缺血性溃疡,有证据表明治疗结果与溃疡相关的研究,如视觉模拟量表(VAS),踝关节-肱指数(ABI)测量,溃疡愈合率和时间,复发率,和并发症。排除标准包括重复研究、重叠研究数据、用于治疗非溃疡性疾病的TTT、其他系统评价、非英语出版语言的文章、无法获得文章全文和病例报告。结果:最终入选13篇文献,涉及924例患者,其中724例患者接受了TTT治疗,其中701例为糖尿病患者。提取的结果显示在愈合率和时间、血管内皮生长因子、ABI评分、VAS评分和肢体保留方面均有改善。在并发症和风险方面,钉位感染和胫骨骨折发生率低且治疗迅速。结论:总的来说,TTT的使用在改善下肢缺血性溃疡的血运重建和愈合时间方面取得了不同寻常的成功,从而为患者带来了更好的结果,并且可能为目前临床实践中使用的更传统、更广泛的治疗提供了潜在的替代治疗方法。胫骨骨折和针位感染是相对罕见的并发症,已报道使用这种治疗。
A Systematic Review on Tibial Cortex Transverse Transport in the Treatment of Ischemic Ulcers of the Lower Limb.
Background: Ischemic foot ulcers are a debilitating but common finding from many different conditions and can result in severe and life-threatening complications such as amputation and death. In recent years, tibial cortex transverse transport (TTT) has been used to treat ischemic ulcers with the aim to improve revascularization and wound healing. Our aim with this systematic review is to analyze the current literature to study the effects this surgery has on the treatment of ischemic ulcers of the lower limb.
Methods: A search was conducted using the 3 databases Web of Science, PubMed, and Scopus to collate all articles associated with the use of TTT in the treatment of lower limb ischemic ulcers. Duplicate articles were removed, and the remaining articles were filtered and screened using set inclusion criteria such as patients with a diagnosed foot ulcer of ischemic origin, patients treated with TTT alone or combined with other techniques on the affected leg, unilateral or bilateral ischemic ulcers, studies that had evidence of treatment outcomes related to ulcer such as visual analog scale (VAS), ankle-brachial index (ABI) measurements, ulcer healing rate and time, recurrence rate, and complications. The exclusion criteria consisted of duplicated studies, overlapping data in studies, TTT used to treat nonulcerous conditions, other systematic reviews, articles with publication language other than English, no access to full text of article, and case reports.
Results: A total of 13 articles were included in the final selection, involving 924 patients, with 724 treated with TTT, in which 701 were diabetic patients. The results extracted demonstrated improvements in healing rates and times, vascular endothelial growth factor, ABI scores, VAS scores, and limb salvage. With regard to the complications and risks, pin-site infections and tibial fractures were infrequent and treated quickly.
Conclusion: Overall, the use of TTT has been associated with unusual success in improving revascularization and healing times in treating ischemic ulcers of the lower limb resulting in better outcomes for the patient and may provide a potential alternative treatment to the more conventional, widespread treatments currently used in clinical practice. Tibial fractures and pin-site infections are relatively rare complications that have been reported with use of this treatment.